Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 9 matches for

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.

Strong immune responses in myeloma patients after two doses of COVID vaccine

Researchers develop cheap, quick COVID-19 antibody test

Persistent immune memory of COVID-19 found in recovered patient T cells

New Nature Immunology paper finds strong T cell responses in recovered COVID-19 patients

Serum iron may be useful biomarker to identify COVID-19 disease severity

Oxford-Sri Lanka study to compare COVID-19 immune response

Study co-led by MRC HIU/MRC WIMM's Professor Graham Ogg.

T cell responses may be key to fighting off COVID-19

Coronavirus research at the MRC WIMM